Senior Key Account Director – Biotech/Pharma Access

Madrigal Pharmaceuticals, Inc.; Northern (KY); Hybrid; USD 217,000 - 266,000; Full time

Job summary

Madrigal Pharmaceuticals, Inc. is seeking a Key Account Director to lead access initiatives for Rezdiffra within regional IDNs and HCP groups. You will collaborate across teams to drive adoption, engage with executive stakeholders, and develop strategic account plans in a dynamic, compliant environment.

The role emphasizes deep MAFLD/MASH disease understanding, cross-functional collaboration, and travel up to 60–80% to manage key accounts across regions.

Qualifications

• Bachelor’s degree required.
• Proven track record of 12+ years of successful account management in biotech/pharma.
• Extensive customer relationships with key account RX and Medical Directors.
• Ability to travel 60-80% and meet targets.

Responsibilities

• Represent Madrigal with IDNs and large HCP Super Groups, engaging with C-suite executives and medical directors.
• Articulate messaging within PI labeling and health economic data.
• Drive engagement with insights on MAFLD/MASH disease continuum and formulary changes.
• Collaborate with cross-functional teams to develop account plans and optimize sales performance.
• Foster MML/HEOR/Marketing interactions with customers and stakeholders.
• Ensure activities comply with all laws and company policies.

Skills

Account management

Stakeholder management

Travel planning

Project management

MS Office

Education

Bachelor’s degree

Tools

MS Office (PowerPoint, Word, Excel)

Job description

Madrigal Pharmaceuticals, Inc. is seeking a Key Account Director to lead access initiatives for Rezdiffra within regional IDNs and HCP groups. You will collaborate across teams to drive adoption, engage with executive stakeholders, and develop strategic account plans in a dynamic, compliant environment.

The role emphasizes deep MAFLD/MASH disease understanding, cross-functional collaboration, and travel up to 60–80% to manage key accounts across regions.